UnitedHealth Group (UNH) recently staged an impressive recovery rally, but the momentum is already fading. The stock briefly broke above the critical $400 resistance level for the non-first time since its drastic price drop in May 2025. 

But buyers were not able to maintain the rally and the price turned back downwards. This sudden pullback leaves investors wondering if the healthcare giant will slide back toward the $300 mark.

Strong Q1 Earnings vs. Market Skepticism

The recent selloff comes despite a very successful first quarter earnings report released on April 21, 2026. The company beat analyst estimates with an $111.7 billion in revenue and adjusted earnings per share of $7.23.

The company’s internal efficiency was also good. Its Medical Care Ratio, its share representing the percentage of premiums paid toward medical claims, improved significantly, to stand at 83.9%. A lower ratio is indicative of increased profitability. 

Additionally, UnitedHealth adopted cutting-edge technology by rolling out Avery, a generative AI-chatbot that simplifies operations and boosts customer engagement.

Why the Rally Lost Steam

If finances look good, why is the stock struggling? Warren Buffett’s Berkshire Hathaway was dealt a major blow when it slaughtered its 3.3 million share stake in the company. The high-tech departures added to worries about immediate future growth.

Moreover, the overall healthcare industry continues to experience headwinds. Wall Street remains concerned about the reasons for medical cost inflation and stringent regulatory challenges. While CMS posted a 2.48% pay rate increase for 2027, Medicare Advantage margins continue to face a degree of uncertainty.

Technical Outlook: What Comes Next?

The weekly chart from a technical standpoint shows a tough contest. UNH managed to pull above its 50 week simple moving average (SMA) which held growth in check for all of 2025. But the 100 weekly simple moving average capped the move and ended the breakout just above $400.

The $400 level should be retaken and sustained rather quickly or else the stock could be poised to resume the downward trend. Shareholders will now be watching to see whether the business can turn a corner on the Q2 earnings release in late July or early August.